Nanjing Leads Biolabs Co., Ltd. (09887)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Cai Shengli01-Jul-22CMedO
Chen Renhai01-Jul-17NED, MbAC
Du Jiliu25-Jul-25INED, MbNC
01-Oct-24INED, ChAC, MbCC
Du Yilong25-Jul-25INED
01-Oct-24INED, MbAC, ChCC
Jian Xuegen25-Oct-24J-CoSec
Jin Hui01-Sep-20ChSup, Sup
Kang Xiao Qiang25-Jul-25Co-Fdr, Ch, CEO, AuRep, GM, ChNC
01-Nov-12ED
Lai Shou Peng25-Jul-25Co-Fdr, CSO, ExVP
01-Mar-14ED
Li Mengwei01-Jul-24Sup
Ling Hong01-Jul-20SVP, CSciO
Wang Zhou01-May-23Sup
Wu Fenglan15-May-26NED
Zhang Hong Bing27-Mar-26ChNC
25-Jul-25INED
01-Oct-24INED, MbNC
Zhang Yincheng01-May-23NED, MbCC
Zuo Honggang01-Oct-24ED, CFO, BrdSec, J-CoSec, AuRep
Ni Jia01-Jul-2427-Mar-26NEDDr. Ni has decided to step down from his current business engagements, including those with his former employer, Shanghai Zhengxingu Investment Management Co., Ltd., and with the Company, in order to devote more time to his other future business commitments.
Du Yilong01-Oct-2425-Jul-25MbNCIn response to the amended Corporate Governance Code and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited which has come into effect on July 1, 2025.